Navigation Links
The Lancet Publishes Vasogen's ACCLAIM Results
Date:1/18/2008

MISSISSAUGA, ON, Jan. 18 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) today announced that The Lancet, a world-leading medical journal, will publish an article entitled 'Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial' in its January 19th issue (Lancet 2008; 371: 228-36). The article describes the results from Vasogen's 2,400-patient ACCLAIM trial of its Celacade(TM) system in patients with chronic heart failure. Celacade is designed to target the destructive chronic inflammation underlying the development and progression of chronic heart failure.

The interpretation of the findings in The Lancet is that: "Non-specific immunomodulation (Celacade) may have a role as a potential treatment for a large segment of the heart failure population, which includes patients without a history of myocardial infarction (irrespective of their functional NYHA class) and patients within NYHA class II."

While the ACCLAIM study did not meet its primary endpoint for the intent-to treat-population, this primary endpoint was met for two large pre-specified subgroups of patients. In the trial, Celacade was shown to significantly reduce the risk of death or cardiovascular hospitalization by 39% in the subgroup of 689 patients with NYHA Class II heart failure, and by 26% in the subgroup of 919 patients with no prior history of heart attack. Importantly, the large risk reduction observed in these subgroups was achieved on top of the benefits derived from current standard-of-care medications and device therapy for heart failure.

"We are extremely pleased with the publication of the ACCLAIM results in The Lancet," commented Chris Waddick, President a
'/>"/>

SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
2. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
3. Consortium publishes Phase II map of human genetic variation
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. CNS Response Announces Fiscal Third Quarter 2007 Results
9. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...tientswithadvanced-stage,orrecurrentendometrialcan.../-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the"C...ndocrinetherapyandoncology,todayannouncedpositivee...cpeptideconjugate,AEZS-108(formerlyAN-152),inpatie...sonalizedhealthcareapproach,thestudyselectedpatien...
(Date:11/24/2009)...althRoboticstodayannounced,thatithasformedanewCana...srecentlyformedToronto-basedcompanywilloperateunde...stall,andsupport,HealthRobotics,i.v.RoomoftheFutur...ringsi.v.STATION(TM),i.v.SOFT(TM),andOMM(TM).,Heal...asneeded,basis"toitsstrategicpartnershipswithMcKes...
(Date:11/23/2009)...ami very high-tech origami. , Researchers at the... for fabricating three-dimensional, single-crystal...g photolithography and a self-folding process driv... few microns thick, offer mechanical bendability t...e material. , "This is a completely different app...
(Date:11/23/2009)...all/--NeogenCorporation(Nasdaq: NEOG )announcedtod...oardofDirectorsatthecompany,srecentannualmeetingof...erienceinthefood,agriculture,andtradeindustriesand...conomicsatVirginiaTechUniversity.FromJanuary2006un...egotiatorwiththerankofambassador. ,, "Sinceourf...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Water droplets direct self-assembly process in thin-film materials 2Richard T. Crowder Joins Neogen's Board of Directors 2
...k Loan With Interest Payment Subsidy, BEIJING, Oc...Amex:,SVA), a vaccine-focused biotech company in C...n Enterprises Credit Promotion Association at the,... an annual Business,Credit Rating program. As part... Company") credit rating was successfully upgraded...
...path toward making useful superconducting devices ...nductors at the nanoscale the realm of billionths...be useful in devices such as superconductive trans...lectronics. , In the October 9, 2008, issue of N...y,s (DOE) Brookhaven National Laboratory report th...
...nces,Corporation (Nasdaq: MATK ) announced today ...rd Adams Healthy Living Conference being held on,O..., MA. Pete Buzy, CFO and,David Abramson, President...Wednesday, October 15., A live audio webcast of M...ww.newswire.ca/en/webcast/viewEvent.cgi?eventID=24...
Other Biology Technology:Sinovac's Credit Rating Upgraded to AAZ, Second Highest Rating 2Sinovac's Credit Rating Upgraded to AAZ, Second Highest Rating 3Scientists engineer superconducting thin films 2
(Date:11/23/2009)...a biomedical engineer and cardiologist Tzung "John...ians distinguish cardiac emergencies requiring imm...th drugs and lifestyle change. , Angiograms, ima...eeding the heart, offer an inside view of the inte...en revealing deposits of a dangerous fatty substan...
(Date:11/23/2009)... , , , , , , , ...Dr Andrew Marshall, from the Environment Departmen...ry of Kinyongia magomberae and his wider work in...e information. , , , , , ... , , , , , , A new species of chamele...
(Date:11/23/2009)...n Institute for Child Health Research has found ev...mption in pregnancy affects child behaviour in dif... online in the international journal Addiction . ...was drawn from a random sample of more than 2000 m...after the baby,s delivery, and were then followed ...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3New study links alcohol in pregnancy to child behavior problems 2Strativas New Drug Application for Ondansetron Orally Dissolving Film Strip Accepted by FDA 12557 1Strativas New Drug Application for Ondansetron Orally Dissolving Film Strip Accepted by FDA 12557 2Strativas New Drug Application for Ondansetron Orally Dissolving Film Strip Accepted by FDA 12557 3The Pressure Is on for African Americans with Hypertension 48419 1The Pressure Is on for African Americans with Hypertension 48419 2The Pressure Is on for African Americans with Hypertension 48419 3The Pressure Is on for African Americans with Hypertension 48419 4The Pressure Is on for African Americans with Hypertension 48419 5The Pressure Is on for African Americans with Hypertension 48419 6Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 1Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 2Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 3Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 4Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 5Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 6Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 7Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 8Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis C Virus 28HCV 29 48416 9
...ltivation of shrimp and fish in tropical coastal a...ndly way to alleviate poverty, but in fact this cu...ocal population and the environment. Daniel A. Be... how policies for sustainable development can go s...in artificial ponds has increased dramatically in ...
...request of the Nigerian government, the IAEA deplo... transport several potentially hazardous radioacti...Nuclear Fuel Cycle and Waste Technology department...thin Nigeria to safely recover the radiological so...turn to Canada or processing at a Nigerian waste f...
...ff erosion prediction, an automatic cameraman, wal...puters with common sense, origami optics, privacy-...oucan beaks, and stem cell control with nano-scien...ojects from every corner of the engineering world ...ol of Engineering graduate students on Thursday 21...
Other Biology News:Global trade in tiger shrimp threatens environment 2IAEA helps recover stray radioactive sources in Nigeria 2
...3; PCR System is the only PCR system that ensures ...provides accuracy, consistency, and dependability ...of the DNA templates. This system uses EPICENTRE's...thermostable enzymes that is capable of amplifying...
...s were cultured in DMEM and harvested at the log p...their native forms, cells were fixed in acetone-me... adhesive coated slide, with each wells surface sp...and to minimize background staining. Each well is...
...ion: Workstation for PCR set-up Easy to assemb...PCR tubes, strips or Nunc 96 Well Amplifications ... Removable tray can be fitted directly into the t...be block thermal cycler formats of major manufactu...
...#153 vector can be induced prior to DNA purificati...e stability of single-copy BACs with the high yiel...s. The kits provide the linearized vector and asso...reening system) necessary to create a 10X human BA...
Biology Products: